Diagnostics

Clinical and radiological features of NMOSD 2:06
Clinical and radiological features of NMOSD
Amy Kunchok • 25 Feb 2022
The central vein sign in multiple sclerosis 2:13
The central vein sign in multiple sclerosis
Pascal Sati • 26 Feb 2022
The central vein sign: a novel imaging biomarker for MS diagnosis 1:05
The central vein sign: a novel imaging biomarker for MS diagnosis
Pascal Sati • 26 Feb 2022
Clinical validation of the MSDA test 1:52
Clinical validation of the MSDA test
Ferhan Qureshi • 24 Feb 2022
An independent focal inflammation cohort – performance of the MSDA validation test algorithm 1:37
An independent focal inflammation cohort – performance of the MSDA validation test algorithm
Ferhan Qureshi • 24 Feb 2022
Highlights from ACTRIMS: comorbidities & paramagnetic rim lesions in MS 2:00
Highlights from ACTRIMS: comorbidities & paramagnetic rim lesions in MS
Burcu Zeydan • 24 Feb 2022
Crucial findings in progressive MS 1:17
Crucial findings in progressive MS
Jason Plemel • 25 Feb 2022
Using machine learning predictions to design more efficient MS clinical trials 5:28
Using machine learning predictions to design more efficient MS clinical trials
David Li-Bland • 2 Mar 2022
Paramagnetic rim lesions in multiple sclerosis 1:13
Paramagnetic rim lesions in multiple sclerosis
Jiwon Oh • 25 Feb 2022
Specific sex differences in MS prognosis 2:52
Specific sex differences in MS prognosis
Burcu Zeydan • 26 Feb 2022
Central sleep apnea phenotyping 1:57
Central sleep apnea phenotyping
Winfried Randerath • 14 Mar 2022
The challenges of screening and diagnosing multiple sclerosis 2:22
The challenges of screening and diagnosing multiple sclerosis
Gavin Giovannoni • 1 Mar 2022
Developments in biomarkers for MS susceptibility and prodrome 1:30
Developments in biomarkers for MS susceptibility and prodrome
Raphael Schneider • 2 Mar 2022
Central vein sign to aid in MS diagnostics 1:20
Central vein sign to aid in MS diagnostics
Jiwon Oh • 25 Feb 2022
The importance of the MS prodrome in early diagnosis 0:47
The importance of the MS prodrome in early diagnosis
Mitzi Joi Williams • 25 Feb 2022
Key developments in MS: RIS, the MS prodrome, & novel MRI biomarkers 2:09
Key developments in MS: RIS, the MS prodrome, & novel MRI biomarkers
Celia Oreja-Guevara • 24 Feb 2022
The content of VJNeurology is intended for healthcare professionals